Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trialsBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3767 (Published 28 May 2012) Cite this as: BMJ 2012;344:e3767
- Bob Roehr
- 1Washington, DC
A coalition of drug companies and major medical journal publishers has recommended 10 steps to help refurbish the tarnished credibility and enhance the quality and transparency of the reporting of industry sponsored clinical trials. The 10 steps were published in the May issue of the Mayo Clinic Proceedings.1
The Medical Publishing Insights and Practices Initiative (MPIP) was established in 2008 by leading drug companies and medical publishers as an ongoing collaboration (www.mpip-initiative.org). The recommendations grew out of a meeting held in New York in November 2010.
The initiative’s first recommendation is that research should be grounded in the asking and answering of questions …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial